X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17954) 17954
Publication (1072) 1072
Magazine Article (311) 311
Book / eBook (309) 309
Book Review (306) 306
Book Chapter (130) 130
Newsletter (59) 59
Newspaper Article (34) 34
Conference Proceeding (16) 16
Dissertation (11) 11
Trade Publication Article (7) 7
Web Resource (6) 6
Data Set (5) 5
Paper (4) 4
Patent (4) 4
Government Document (2) 2
Journal / eJournal (1) 1
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12588) 12588
index medicus (7845) 7845
administration, oral (6880) 6880
female (6007) 6007
male (5731) 5731
warfarin (5157) 5157
anticoagulants - administration & dosage (5010) 5010
anticoagulants (4722) 4722
anticoagulants - therapeutic use (4588) 4588
aged (4299) 4299
middle aged (3903) 3903
atrial fibrillation (3509) 3509
anticoagulants - adverse effects (3409) 3409
risk factors (3105) 3105
hematology (3036) 3036
adult (2766) 2766
peripheral vascular disease (2735) 2735
oral anticoagulants (2653) 2653
stroke (2600) 2600
cardiac & cardiovascular systems (2529) 2529
dabigatran (2419) 2419
rivaroxaban (2272) 2272
treatment outcome (2257) 2257
atrial fibrillation - drug therapy (2078) 2078
aged, 80 and over (2029) 2029
thromboembolism (2002) 2002
venous thromboembolism (2001) 2001
prevention (1907) 1907
risk (1858) 1858
hemorrhage - chemically induced (1853) 1853
management (1836) 1836
therapy (1796) 1796
medicine, general & internal (1781) 1781
oral anticoagulation (1757) 1757
atrial-fibrillation (1753) 1753
pharmacology & pharmacy (1731) 1731
stroke - prevention & control (1682) 1682
international normalized ratio (1674) 1674
atrial fibrillation - complications (1555) 1555
warfarin - therapeutic use (1503) 1503
anticoagulation (1475) 1475
thrombosis (1471) 1471
warfarin - administration & dosage (1435) 1435
apixaban (1353) 1353
surgery (1287) 1287
care and treatment (1258) 1258
time factors (1254) 1254
animals (1230) 1230
retrospective studies (1218) 1218
oral anticoagulant-therapy (1196) 1196
warfarin - adverse effects (1183) 1183
thromboembolism - prevention & control (1141) 1141
stroke prevention (1129) 1129
bleeding (1110) 1110
analysis (1093) 1093
direct oral anticoagulants (1073) 1073
antithrombotic therapy (1071) 1071
safety (1067) 1067
risk assessment (1033) 1033
vitamin k - antagonists & inhibitors (1028) 1028
abridged index medicus (998) 998
drug therapy (998) 998
medicine & public health (995) 995
blood coagulation - drug effects (993) 993
stroke - etiology (978) 978
deep-vein thrombosis (976) 976
patients (964) 964
aspirin (952) 952
health aspects (919) 919
hemorrhage (918) 918
prospective studies (912) 912
molecular-weight heparin (898) 898
anticoagulants - pharmacology (876) 876
mortality (867) 867
research (863) 863
dose-response relationship, drug (858) 858
prothrombin time (827) 827
follow-up studies (819) 819
cardiac arrhythmia (797) 797
cardiology (793) 793
adolescent (778) 778
metaanalysis (769) 769
risk-factors (769) 769
dosage and administration (761) 761
thrombin (731) 731
internal medicine (704) 704
drug interactions (689) 689
pharmacokinetics (680) 680
efficacy (670) 670
venous thrombosis (654) 654
oral anticoagulant (644) 644
drug administration schedule (639) 639
heparin (636) 636
dabigatran etexilate (625) 625
randomized controlled trials as topic (620) 620
recurrence (615) 615
incidence (607) 607
anticoagulants - pharmacokinetics (596) 596
clinical trials (592) 592
complications (589) 589
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (144) 144
Dentistry (Harry R Abbott) - Stacks (83) 83
Dentistry (Harry R Abbott) - Withdrawn (52) 52
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (51) 51
Gerstein Science - Stacks (51) 51
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Dentistry (Harry R Abbott) - Circulation Desk (7) 7
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Dentistry (Harry R Abbott) - May be requested (6) 6
Dentistry (Harry R Abbott) - Searching (3) 3
Lakeridge Health Sciences - Oshawa (3) 3
Robarts - Stacks (3) 3
Scarborough Hospital - Birchmount (2) 2
St. Michael's Hospital - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Dentistry (Harry R Abbott) - Course Reserves (1) 1
Dentistry (Harry R Abbott) - Mending (1) 1
Dentistry (Harry R Abbott) - Missing (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Regis College - Stacks (1) 1
Royal Ontario Museum - Reference (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - Withdrawn (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16486) 16486
German (665) 665
French (452) 452
Spanish (390) 390
Italian (157) 157
Russian (137) 137
Japanese (93) 93
Portuguese (77) 77
Polish (72) 72
Hungarian (44) 44
Turkish (25) 25
Dutch (24) 24
Czech (21) 21
Danish (20) 20
Norwegian (15) 15
Chinese (14) 14
Swedish (14) 14
Korean (12) 12
Arabic (8) 8
Hebrew (8) 8
Bulgarian (6) 6
Finnish (6) 6
Serbian (6) 6
Slovenian (5) 5
Croatian (4) 4
Romanian (4) 4
Lithuanian (2) 2
Bosnian (1) 1
Estonian (1) 1
Georgian (1) 1
Icelandic (1) 1
Persian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 2012, Volume 59, Issue 16, pp. 1413 - 1425
Journal Article
American Heart Journal, ISSN 0002-8703, 2016, Volume 182, pp. 28 - 35
Background Non-vitamin K antagonist oral anticoagulants (NOACs, dabigatran, rivaroxaban, apixaban, and edoxaban) have been increasingly used as alternatives to... 
Cardiovascular | INTRAVENOUS THROMBOLYSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | DABIGATRAN ANTICOAGULATION | TISSUE-PLASMINOGEN ACTIVATOR | WARFARIN | ACUTE ISCHEMIC-STROKE | GUIDELINES | INTRACEREBRAL HEMORRHAGE | RISK SCORE | HEALTH-CARE PROFESSIONALS | INTRACRANIAL HEMORRHAGE | United States - epidemiology | Dabigatran - adverse effects | Dabigatran - administration & dosage | Anticoagulants - administration & dosage | Humans | Stroke - diagnosis | Warfarin - adverse effects | Male | Thiazoles - administration & dosage | Antithrombins - administration & dosage | Medication Therapy Management - standards | Warfarin - administration & dosage | Rivaroxaban - administration & dosage | Thiazoles - adverse effects | Pyridones - administration & dosage | Pyridines - adverse effects | Rivaroxaban - adverse effects | Adult | Female | Registries | Stroke - therapy | Pyrazoles - adverse effects | Stroke - prevention & control | Pyridines - administration & dosage | Administration, Oral | Atrial Fibrillation - drug therapy | Atrial Fibrillation - complications | Emergency Treatment - methods | Anticoagulants - adverse effects | Outcome and Process Assessment (Health Care) | Pyrazoles - administration & dosage | Stroke - etiology | Quality Improvement | Antithrombins - adverse effects | Emergency Treatment - mortality | Pyridones - adverse effects | Cohort Studies | Stroke (Disease) | Warfarin | Diet therapy | Stroke patients | Atrial fibrillation
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2013, Volume 109, Issue 4, pp. 569 - 579
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2016, Volume 115, Issue 4, pp. 685 - 711
Journal Article
American Heart Journal, ISSN 0002-8703, 2017, Volume 190, pp. 12 - 18
Background Oral anticoagulation prevents ischemic strokes in patients with atrial fibrillation. Early detection of atrial fibrillation and subsequent... 
Cardiovascular | FIBRILLATION | CARDIAC & CARDIOVASCULAR SYSTEMS | STROKE PREVENTION | WARFARIN | CLINICAL-IMPLICATIONS | AMERICAN-COLLEGE | CARDIAC MONITOR | RISK | OPEN-LABEL | TEMPORAL RELATIONSHIP | ISCHEMIC-STROKE | Prospective Studies | Follow-Up Studies | Humans | Male | Thiazoles - administration & dosage | Atrial Fibrillation - physiopathology | Aspirin - administration & dosage | Factor Xa Inhibitors - administration & dosage | Incidence | Time Factors | Female | Stroke - epidemiology | Vitamin K | Heart Rate | Stroke - prevention & control | Pyridines - administration & dosage | Survival Rate - trends | Double-Blind Method | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Europe - epidemiology | Treatment Outcome | Disease-Free Survival | Stroke - etiology | Atrial Fibrillation - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Stroke (Disease) | Care and treatment | Anticoagulants (Medicine) | Stroke patients | Atrial fibrillation | Cardiac patients | Implants, Artificial | Prosthesis | Anticoagulants | Therapy | Cardiac arrhythmia | Surgical implants | Aspirin | Stroke | Coagulation | Strokes | Patients | Bleeding | Risk factors | Vitamins | Artifacts | Fibrillation | Ischemia | Defibrillators | Pacemakers | Safety engineering | Electrocardiography | Heart diseases | Trial Design
Journal Article
1996, ISBN 0340552662, vii, 280
Book
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 11, pp. 1128 - 1139
Abstract Background Non–vitamin K oral anticoagulants (NOACs) do not require routine laboratory monitoring. However, laboratory measurement may be desirable in... 
Cardiovascular | Internal Medicine | dabigatran | rivaroxaban | monitoring | laboratory | apixaban | MEASURING RIVAROXABAN | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | DABIGATRAN CONCENTRATIONS | PROTHROMBIN TIME | PARTIAL THROMBOPLASTIN TIME | COAGULATION ASSAYS | IN-VITRO | FACTOR-XA INHIBITOR | PLASMA-CONCENTRATIONS | INTERNATIONAL NORMALIZED RATIO | Anticoagulants - administration & dosage | Humans | Antithrombins - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Factor Xa Inhibitors - administration & dosage | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - pharmacology | Factor Xa Inhibitors - pharmacology | beta-Alanine - analogs & derivatives | Pyrazoles - pharmacology | Administration, Oral | Morpholines - administration & dosage | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Pyrazoles - administration & dosage | Partial Thromboplastin Time | Anticoagulants - pharmacology | Benzimidazoles - pharmacology | Drug Monitoring | Pyridones - pharmacology | Measurement | Anticoagulants (Medicine) | Vitamins | Studies | Anticoagulants | Plasma | Bibliographic literature | Laboratories | Drug therapy | Drug dosages | Bone surgery
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2014, Volume 127, Issue 11, pp. 1075 - 1082.e1
Journal Article
Blood, ISSN 0006-4971, 01/2010, Volume 115, Issue 1, pp. 15 - 20
Journal Article
Journal Article